Amgen, Inc. (NASDAQ: AMGN) reported Q1 EPS of $1.61, $0.16 better than the analyst estimate of $1.45. Revenue for the quarter came in at $4.05 billion versus the consensus estimate of $3.93 billion.

Reaffirms FY.

For earnings history and earnings-related data on Amgen, Inc. (AMGN) click here.

Earnings